Michael Skynner

Michael Skynner is currently the Chief Technology Officer at Bicycle Therapeutics since January 2016. With previous experience at Pfizer and GlaxoSmithKline, as well as founding Cambridge Biotechnology Ltd, Michael brings a wealth of expertise in drug discovery and development. Michael's academic background includes a PhD in Biochemistry from Imperial College London.